Does insurance cover Mounjaro®? Check your coverage in 2026

Mounjaro^® is now widely used as a treatment for type 2 diabetes and sometimes prescribed off-label for weight loss. As a once-weekly injection made with tirzepatide, it works on two hormone pathways (GLP-1 and GIP) to help regulate blood sugar, slow digestion, and lower appetite. While its results have drawn a lot of attention, cost is often a concern, especially for people wondering whether insurance will help cover it.

Without coverage, the monthly price can be over $1,000, making it important to understand your benefits upfront and your other options. The challenge is that the answer isn’t always clear-cut.

Part of the reason is that coverage depends heavily on how the medication is prescribed. Insurance plans are generally more likely to cover Mounjaro^® when it’s used for type 2 diabetes, though certain regulations often apply. When it’s prescribed off-label for weight loss, coverage is unlikely. Insurance plans aren’t required by law to cover weight-loss medications, and Mounjaro isn’t approved for that use.

Let’s break down when Mounjaro^® is more likely to be covered, why it’s sometimes denied, and how requirements like prior authorization and step therapy come into play. 

We’ll also look at how coverage differs by plan type and what you can expect to pay with and without insurance—so you can better understand your options before starting treatment. And, we’ll talk about how Zepbound can be a more affordable option if weight loss is your primary reason for looking into Mounjaro. 

Is Mounjaro® ever covered by insurance?

Short answer: Yes—but usually only under certain conditions. Coverage isn’t automatic, and it largely depends on why your doctor prescribed it and what type of insurance you have.

Insurance plans are far more likely to approve Mounjaro® for type 2 diabetes. In fact, most commercial plans and Medicare Part D plans cover it for diabetes management. But coverage becomes much more limited when it’s prescribed for weight management. 

Mounjaro® is FDA-approved for blood sugar control, so weight loss is an “off-label” use, which can lead to denials. The other big reason that it’s often not covered is that insurance carriers are not required by law to cover any medications that are solely prescribed for weight loss.

Even when Mounjaro® is covered for diabetes, most plans require prior authorization and step therapy. That means your provider must submit documentation proving you meet specific criteria, and often that you’ve tried other medications first.

Your insurance type matters, too. 

• Private and employer-sponsored plans tend to offer the strongest coverage for diabetes treatment with GLP-1s like Mounjaro. 
• Medicare Part D and Medicare Advantage typically cover Mounjaro® for diabetes, but there may be additional prior authorization requirements. 
• Medicaid may cover it for diabetes in some states.

Insurance coverage of Mounjaro: Private, federal, and state plans

Across most major insurers in 2026, Mounjaro® is more consistently covered for type 2 diabetes, not for off-label weight management. When coverage is available, prior authorization and medical documentation are typically required.

Below is a high-level snapshot of how major insurers approach coverage in 2026. Individual employer plans, formularies, and state rules may vary.

Mounjaro^® coverage: Understanding private insurance plans

Coverage for Mounjaro^® can vary quite a bit depending on your insurance provider and how the medication is prescribed. In general, most major insurers are more likely to cover it for type 2 diabetes, while coverage for weight management is unlikely. The table below gives a snapshot of how several large insurers handle coverage, including common requirements like prior authorization, step therapy, and how plan design or state differences can impact access.

Insurance Provider	Coverage Status	Requirements
Aetna	Commonly covered for type 2 diabetes	Prior authorization; confirmed diabetes diagnosis; may require step therapy
Blue Cross Blue Shield	Often covered for diabetes	Prior authorization; BMI criteria for weight loss if covered
Cigna	Covered for diabetes on many plans	Prior authorization; may require trial of other therapies
UnitedHealthcare	Typically covered for diabetes	Prior authorization; documentation of medical necessity
Kaiser Permanente	Covered for diabetes under many plans; internal review required	Prior authorization; diagnosis documentation
Humana	Covered for diabetes on many commercial and Medicare Advantage plans	Prior authorization; formulary tier placement
Anthem	Commonly covers diabetes	Prior authorization; may require step therapy
Molina Healthcare	Covers diabetes	Prior authorization; Medicaid rules apply where applicable
Ambetter	Often covers diabetes	Prior authorization
Oscar Health	Diabetes coverage common on many plans	Prior authorization; formulary review required
CVS Caremark	Coverage depends on employer or plan sponsor	Prior authorization; step therapy common
Express Scripts	Coverage varies by employer and formulary	Prior authorization; step therapy often required

State Differences: Coverage rules may vary by state, especially for Medicaid and state employee plans.

Mounjaro^® coverage: Understanding Medicare insurance plans

Insurance Provider	Coverage Status	Requirements	Comments	State Differences	Last Reviewed
Medicare Part D	Covered for type 2 diabetes; not covered for weight loss	Must meet diabetes indication; formulary inclusion required	Copays typically $10-$50/month when covered	No (federal program, plan variation exists)	02/2026
Tricare	Covered for type 2 diabetes when medically necessary	Prior authorization; step therapy may apply	Copay around $38 for 90-day supply	No (federal)	02/2026

Mounjaro^® coverage: Understanding Medicaid insurance plans

Insurance Provider	Coverage Status	Requirements	State Differences
Medicaid	Coverage for diabetes in all states	State-specific criteria; prior authorization common	Yes

State-by-state Medicaid coverage for Mounjaro

Where you live can make a real difference in whether Mounjaro® is covered—especially if you’re enrolled in Medicaid. While diabetes coverage is generally required under state Medicaid programs, coverage for medications prescribed for weight management varies significantly by state and would apply to Zepbound®. These differences are driven by state Medicaid expansion status, state benefit design, and whether weight loss treatment is included as a covered benefit.

Below is a snapshot of large states where Medicaid policy differences most often affect access. 

Coverage information may vary and change frequently. Always confirm with your state Medicaid office or insurance provider.

State	Recent changes
California	As of Jan 1, 2026, weight-loss GLP-1s are excluded; coverage remains for diabetes indications
North Carolina	Mounjaro® is listed as a non-preferred drug, meaning two preferred drugs must be tried first
Michigan	Coverage tightened in 2026 with stricter approval requirements, including step therapy.
Delaware	Continues to cover for diabetes with utilization controls
Texas	Not uniform—rules differ across Medicaid managed care organizations
Pennsylvania	Adult coverage rules tightened in 2026; non-diabetes use generally not covered. Requires documentation of intolerance to or failure of Ozempic® or Wegovy®.
New Hampshire	Weight-loss exclusions remain in place as of 2026

How to check if your insurance covers Mounjaro^®

Trying to figure out your coverage? The fastest way to avoid surprise bills is to confirm the details upfront. Here’s a simple, practical checklist you can follow.

Step-by-step insurance coverage checklist

• Call the member services number on your insurance card
  Find out if Mounjaro^® is covered under your pharmacy benefit and for which indication. Request written documentation or a link to your plan’s formulary and coverage policy. You can also review your insurer’s online formulary portal. For example, Medicare Part D plans publish formularies publicly each year.

• Ask about prior authorization (PA)
  Most insurance carriers require prior authorization when they do cover GLP-1 medications, which means your provider will have to submit documentation proving medical necessity. Find out what documentation they require—such as BMI, diagnosis codes, or treatment history.
• Check for step therapy requirements
  Many plans require step therapy, which means you have to try other treatments or medications before Mounjaro^® will be approved. Ask if your plan requires step therapy and, if so, which medications must be tried first.
• Review Medicare or Medicaid rules (If applicable)

• Traditional Medicare Part D doesn’t currently cover medications prescribed solely for weight loss. They might if used for another FDA-approved indication.
• Medicaid coverage varies by state.
• Use official coverage tools
  Eli Lilly provides a manufacturer coverage resource to help people understand potential insurance pathways.
• Get everything in writing
  Whether your coverage is approved, denied, or requires additional documentation, request written confirmation. This documentation will be helpful if you need to file an appeal.

Mounjaro and insurance: What determines coverage?

Coverage decisions usually come down to a few core factors — and knowing them can help you avoid surprises.

1. FDA approval & your diagnosis

The single biggest factor is what condition your doctor is treating.

Mounjaro® (tirzepatide) is FDA-approved for type 2 diabetes. Because of that, insurers are far more likely to cover it when prescribed for diabetes management. Coverage is unlikely when it’s prescribed for weight management.

2. Prior authorization requirements

Even when Mounjaro® is on your plan’s formulary, most insurers require prior authorization.

That means your healthcare provider must submit documentation showing:

• A confirmed diagnosis (typically type 2 diabetes)
• Medical necessity
• In some cases, trial or failure of other therapies first (step therapy)

Prior authorization is a standard utilization management tool used by commercial plans, Medicare Part D, and Medicaid programs.

Cost of Mounjaro® with and without insurance

Understanding the cost of Mounjaro® in 2026 is essential before starting treatment, especially since coverage varies widely by diagnosis and insurance plan. Without insurance, the list price is about $1,080 per month. 

Actual retail prices at pharmacies may vary slightly, but most uninsured people can expect to pay around that amount out of pocket. With insurance, what you pay depends on your specific plan, formulary tier, and deductible.

Here’s what that typically looks like:

• Without insurance: About $1,080 per month (list price; pharmacy prices may vary)
• With commercial insurance (if covered): Copays often range from $25 to $150, depending on plan design
• With Medicare Part D (if covered for diabetes): Costs vary by plan phase (deductible, initial coverage, catastrophic phase); weight-loss use is not covered under federal law.

Eli Lilly also offers a Mounjaro® Savings Card for eligible commercially insured people, which may reduce costs significantly if coverage criteria are met. Because formularies, deductibles, and eligibility rules change, the most accurate way to estimate your cost is to confirm directly with your insurer and pharmacy before filling your prescription.

Savings options

If insurance coverage falls short — or isn’t available — you still have options. The key is understanding which savings programs apply to your situation and whether you have commercial insurance, government insurance, or no coverage at all.

Manufacturer savings cards (Eli Lilly)

Eli Lilly offers a Mounjaro^® Savings Card that is available to eligible people with commercial insurance. If your plan covers Mounjaro^®, the savings card may reduce your copay to as little as $25 per month for a 1-, 2-, or 3-month prescription, depending on eligibility and plan details.

These savings are subject to maximum limits, including:

• Up to $150 savings per 1-month prescription
• Up to $300 savings per 2-month prescription
• Up to $450 savings per 3-month prescription
• A separate annual savings cap of up to $1,950 per calendar year
• The card can be used for up to 13 prescription fills per year

If you have commercial insurance that doesn’t cover Mounjaro®, the program may still offer a reduced price—bringing the cost down to as low as $499 per month for a 1-month supply. In this case, savings are capped at up to $647 per month and up to $8,411 annually, with the same 13-fill limit.

To qualify, you must have a prescription for an FDA-approved use, be enrolled in a commercial (non-government) insurance plan, be 18 or older, and live in the U.S. or Puerto Rico. The program isn’t available to people enrolled in Medicare, Medicaid, TRICARE, VA, or other government-funded healthcare programs.

Keep in mind that the savings card does not replace insurance coverage—it works alongside it to reduce out-of-pocket costs. Program terms can change, and the current offer is set to run through December 31, 2026.

Patient assistance programs

Independent nonprofits like the PAN Foundation and HealthWell Foundation may offer financial assistance grants for eligible people with certain diagnoses, depending on available funding.

Availability and eligibility can change, so checking directly is important.

Mounjaro: Costs without insurance

For those without insurance, the Mounjaro^® list price is $1,080 per month, depending on dose and pharmacy. The manufacturer isn’t offering discounted self-pay pricing at this time. But Zepbound^® might be more affordable if you are looking for tirzepatide for weight loss. 

Zepbound^® contains the same active ingredient (tirzepatide) in the same doses. It can also be difficult to get covered by insurance, but Eli Lilly offers lower, self-pay prices. Here’s a breakdown of the self-pay pricing for Zepbound^®.

These prices are available for people without insurance coverage who fill prescriptions through Eli Lilly’s pharmacy platform. They apply to both single-dose vials and new multi-dose KwikPen^® formats.

Monthly pricing:

• 2.5 mg: $299
• 5 mg: $399
• 7.5 mg, 10 mg, 12.5 mg, 15 mg: $449

Learn more about: Zepbound cost without insurance: What to expect in 2026

Frequently asked questions about insurance coverage and Mounjaro®

These answers address the most common concerns about getting approved to take Mounjaro®, understanding coverage decisions, and finding affordable options.

Can you get approved for Mounjaro® without diabetes?

Yes, a healthcare provider may prescribe Mounjaro® off-label for weight loss. But insurance plans are unlikely to cover it without a diabetes diagnosis. In those cases, people often face the full list price, which is approximately $1,080 per month.

Why is Mounjaro® not covered by insurance for weight loss?

Since Mounjaro® is approved for type 2 diabetes—not weight loss —nearly all plans won’t cover it when prescribed solely for weight management, even if weight loss coverage is a part of the plan. 

How can you get insurance to cover Mounjaro?

If your plan covers it for diabetes, your provider will usually need to submit prior authorization documentation confirming your diagnosis and medical necessity. Some plans may also require step therapy, meaning you must try other medications first. Checking your formulary and starting the authorization process early can help avoid delays.

How much is Mounjaro® with insurance coverage?

With commercial insurance coverage, copays commonly range from about $25 to $150, depending on your plan’s tier and deductible structure. Medicare Part D costs vary by plan phase (deductible, initial coverage, catastrophic phase), but coverage applies only when prescribed for diabetes. Actual costs depend entirely on your specific plan design.

How do you get Mounjaro® for $25?

Eligible people whose plans cover Mounjaro® may qualify for the manufacturer savings card, which can reduce copays significantly. The card cannot be used with Medicare, Medicaid, or other government insurance programs. Details and eligibility are available directly from Eli Lilly.

What is the cheapest way to get Mounjaro?

If you have commercial insurance that covers it, using the manufacturer’s savings card is often the lowest-cost option. If you don’t have coverage, you can consider getting Zepbound through Lilly Direct. Zepbound has the same doses of tirzepatide under a different brand name.

How much weight can you lose on Mounjaro® in 3 months?

In clinical trials of tirzepatide, participants experienced meaningful weight reduction of an average of 6 to 8% of body weight in the first three months, though results vary based on dose and individual factors. 

Early weight loss often begins during the dose-escalation phase, but full results are typically evaluated over longer study periods. Individual outcomes depend on factors like dose, starting weight, nutrition, and daily habits.

It’s worth noting that weight loss tends to be slightly lower in people with type 2 diabetes compared to those without diabetes. That’s been a consistent finding across studies, likely due to differences in metabolism, insulin resistance, and concurrent medications.

Learn more: Mounjaro® dosage guide: How to find the right dose for weight loss

How to get Mounjaro® if insurance won’t cover it?

If your insurance won’t cover Mounjaro®, ask your provider about submitting an appeal or additional prior authorization documentation, and explore manufacturer savings programs or patient assistance options that may reduce costs. 

The bottom line: Mounjaro® is likely only going to be covered for diabetes management

Whether Mounjaro^® is covered by your insurance really comes down to why it’s prescribed and the details of your specific insurance plan. Coverage is much more common when it’s used for type 2 diabetes, but unlikely for weight management.

If you’re considering Mounjaro^®, the best next step is to check your formulary, understand any prior authorization or step therapy requirements, and talk with your provider about your diagnosis and goals. A little upfront legwork can go a long way in avoiding surprises—and helping you find the most affordable path forward.

If you’re specifically looking to use tirzepatide for weight loss, Zepbound^® is the best option. It contains the same active ingredient (tirzepatide) in the same doses, and is approved for weight management. 

While it is still challenging to get it covered for weight loss, it has self-pay options through LillyDirect from $299 to $449 per month, depending on dose.

If you qualify, Noom Med can help you find the right medication and prescribe it when appropriate. It combines clinical care—including evaluation and support for side effects—with Noom’s tools, trackers, community, and guidance on exercise and protein to help you maintain muscle while losing weight. We’ll show you how to build habits that actually stick.

Note: Mounjaro® is not FDA-approved to treat obesity or for weight loss.